Measuring the load of GN bacteria and the levels of IL-6 may allow further refinement of the asthma diagnosis as type 2 versus non-type 2, for exploration of other asthma phenotypes (e.g., the IL-6-high phenotype recently described)40,45, and may also inform which patients could be treated more aggressively for ongoing asthmatic inflammation. Here, IL6 is linked to asthma.